Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

During the Trading Day
40.27 -1.98 / -4.69%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
40.27 -0.0048 / -0.01%
 
Volume: 24.9K

Today’s Trading

Previous close42.25
Today’s open41.99
Day’s range40.21 - 42.78
Volume716,321
Average volume (3 months)868,183
Market cap$5.3B
Dividend yield--
Data as of 3:59pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-56.34%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book24.84

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC-1.26-4.13%
TAROTaro Pharmaceutical ...-1.31-0.97%
AKRXAkorn Inc-1.24-3.02%
ANACAnacor Pharmaceutica...-5.04-3.72%
Data as of 4:08pm ET, 08/31/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

Partner Offers